NICUSeq: Clinical whole genome sequencing

NICUSeq Study

Le Bonheur was one of five children’s hospitals to participate in a randomized clinical trial, coordinated by Illumina, Inc. scientists, to determine the effect of clinical whole-genome sequencing (cWGS) on clinical management of critically-ill newborns in the U.S.

Study: Trigeminal autonomic cephalalgias

All five headache disorders comprising trigeminal autonomic cephalalgias (TAC) can begin early in life and exhibit many of the same symptoms as TACs in adults.

Creating Value

Many roles of a centralized pediatric fellowship office

Pay It Forward And Make A Difference.

Help us support other families like these by donating.

Donate Now

Intervening for IBD

Research shows potential of psychological intervention to improve quality of life for at-risk adolescents with inflammatory bowel disease (IBD)

Speaking Up for Children with TSC

Research shows infants with tuberous sclerosis complex (TSC) have delayed precursors of speech development

Briefs

News about what's happening at Le Bonheur Children's Hospital

Research Matters:

Research About Le Bonheur About University of Tennessee Health Science Center
Download PDF of this issue About Le Bonheur Past Issues Get Involved Contact Media Relations

Le Bonheur Children's Hospital in Memphis, Tenn., treats more than 500,000 children each year in regional clinics and a 311-bed hospital that features state-of-the-art technology and family-friendly resources. Our medical staff of more than 240 physicians provide care in 40 subspecialties.

For referrals contact Le Bonheur Connect at 1-866-870-5570.

Research Matters is a publication of Le Bonheur Children's Hospital, produced by Le Bonheur Marketing and Communications Services.